hiPSCs from NS/JMML and NS patients with <em>PTPN11em> mutations model JMML
The hiPSC model reveals features of early oncogenesis
CD33+ myeloid cells from NS/JMML hiPSCs exhibit miR-223 dysregulation
MicroRNA dysregulation provides a genotype-phenotype association for JMML